
TREATMENTS
Exploring new frontiers for the treatment of Autism
TREATMENTS
Exploring new frontiers for the treatment of Autism
17+ Years of using patented and proven stem cell treatment for Autism
Autism is a complex developmental disorder, as a result of neurological trauma which affects normal brain function. The condition causes mild to severe impairment in the normal brain development of the child. The disorder is mainly characterized by weakened social interaction, impaired verbal or non-verbal communications and indulgence in repetitive behaviour.
The traditional approach attempts to treat Autism by involving the use of antibiotics, anti‐inflammatory agents and hyperbaric oxygen. Although, till date, there is no complete cure available for autism that addresses the root cause of the condition, stem cell treatments are designed after assessing the clinical condition of the patient. Once eligible, the cells are administered in the patient’s body using our proprietary, non-invasive stem cell platform, ReoStem®.
Once the stem cells are administered in the body through veins, these cells can reach the targeted site and help reboot and revive the damaged nerve cells to restore their function back. Nutech MediWorld’s Stem Cell Treatment helps revive the damaged neurons. In addition, they have the potential to stimulate cells to boost up the repair leading to improvement in impaired functions. These stem cells have also observed to be promoting angiogenesis to increase oxygen supply to the blood for a speedy recovery from Autism.
We assess the patients’ clinical condition using conventional systems to check their eligibility as it is a key criterion for stem cell treatment to address Autism.
We also conduct an additional round of thorough assessment using our NFS (Nutech Functional System) protocols whereby condition-based sets of parameters have been pre-devised for a finer assessment of the patient’s condition (and progress).
After evaluating the specific patient’s condition, a unique/bespoke treatment protocol is decided. This protocol is based on our proprietary stem cell platform, Reostem®.
The patient’s progress is monitored on a weekly basis to further optimize treatment protocols depending on the patient’s response.
At the end of the treatment, a complete assessment is done to track progress from when the patient came into where he/she has reached now. If required, a follow-up protocol is recommended.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Autism patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Autism Patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient
We assess the patients’ clinical condition using conventional systems to check their eligibility as it is a key criterion for stem cell treatment to address Autism.
We also conduct an additional round of thorough assessment using our NFS (Nutech Functional System) protocols whereby condition-based sets of parameters have been pre-devised for a finer assessment of the patient’s condition (and progress).
After evaluating the specific patient’s condition, a unique/bespoke treatment protocol is decided. This protocol is based on our proprietary stem cell platform, Reostem ®.
The patient’s progress is monitored on a weekly basis to further optimize treatment protocols depending on the patient’s response.
At the end of the treatment, a complete assessment is done to track progress from when the patient came into where he/she has reached now. If required, a follow-up protocol is recommended
We use SCT-N® and SCT-NX® products, based on a proprietary stem cell platform, ReoStem®. ReoStem® is a unique, replicable, clinical-stage technology platform for the generation of allogenic stem cells.
Nutech MediWorld’s regenerative medicine products are universally applicable: they do not require tissue-matching or the co-administration of immunosuppressive drugs.
There is absolutely no evidence of teratoma generation or tumorigenesis associated with SCT-N® or SCT-NX® use in over 17 years of clinical practice across thousands of patients.
Unique cell culture methodology allows scalability of cell expansion and production.